018745666

SELARSDI

---

August 8, 2022

Trademark Summary

The trademark application SELARSDI was filed by TEVA PHARMACEUTICALS USA, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 15, 2022, and it was registered by office on December 23, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease
  2. Pharmaceutical preparations for the prevention and treatment of depression
  3. Pharmaceutical preparations for the prevention and treatment of psychological disorders
  4. Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy
  5. Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders
  6. Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome
  7. Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders
  8. Pharmaceutical preparations for the prevention and treatment of osteoporosis
  9. Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain
  10. Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders
  11. Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders
  12. Pharmaceutical preparations for the treatment of auto-immune diseases
  13. Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders
  14. Pharmaceutical preparations for the prevention and treatment of sexual dysfunction
  15. Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids
  16. Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder
  17. Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders
  18. Pharmaceutical preparations that support, encourage and promote bone strength
  19. Pharmaceutical preparations that support, encourage and promote bone health
  20. Pharmaceutical preparations used in the treatment of bone disorders and bone diseases
  21. Pharmaceutical preparations, namely, injectable contraceptives
  22. Pharmaceutical preparations, namely, contraceptive preparations
  23. Pharmaceutical preparations, namely, fertility enhancement preparations
  24. Pharmaceutical preparations, namely, hormone replacement therapy preparations
  25. Pharmaceutical preparations for the treatment of cancer
  26. Pharmaceutical agents affecting the central nervous system
  27. Pharmaceutical agents affecting circulatory systems
  28. Pharmaceutical agents affecting sensory organs
  29. Pharmaceutical agents affecting urogenital organs
  30. Pharmaceutical agents affecting peripheral nervous system
  31. Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications.